S2889
RTT - RTT education, training, and advanced practice
ESTRO 2026
Digital Poster Highlight 4419 Inequitable Access to Late Effects Services After Radiotherapy: A National Audit Caroline Fadipe 1 , Marina Khan 1 , Ingrid White 2 1 Radiotherapy, Guys and St Thomas NHS Foundation Trust, London, United Kingdom. 2 Clinical Oncology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom Purpose/Objective: To evaluate the extent to which current provision of therapeutic radiographer (RTT) support related to late effects after pelvic radiotherapy in gynaecological cancer matches existing published consensus guidelines1,2. Material/Methods: In August 2025, 56 UK NHS radiotherapy managers were sent an electronic questionnaire designed to assess compliance with consensus guidelines on the management of late effects after pelvic radiotherapy. A total of 75 questions were included in the questionnaire, focusing on four key areas: (1) use of validated questionnaires for assessing radiotherapy- related toxicity, (2) departmental guidelines, (3) referral pathways, and (4) access to specialist late effects services and expertise. Results: There were 40 (71 %) responses. Of those that responded 54.7 % reported that their department had clear guidelines in the management of late effects and 32.2 % reported that there were established criteria for referring patients on for specialist management. There were clearly defined pathways for referral in 45.1% of responses. A dedicated late effects service for patients with gynaecological cancer treated with pelvic radiotherapy was reported in only 42.5 % of departments; however, this tumour site had the greatest overall provision of late effects clinics. In centres where there were dedicated late effect services these were usually run by RTTs (48.4 %). Most of these did not have a dedicated Multidisciplinary Team to discuss complex cases. Knowledge of validated assessment tools for pelvic radiotherapy side effects in patients treated for gynaecological cancer was poor (figure 1)
and review and recording of late effects using a recognised toxicity score was also lacking, with only 20 % of respondents using validated questionnaires. Conclusion: There is wide variation in RTT assessment, management and referral pathways for patients with pelvic radiotherapy late effects across radiotherapy departments in the UK. There is a significant gap in support, investigation and management of late effects after pelvic radiotherapy in gynaecological cancer. The majority of established clinics rely on charitable funding, while others operate without dedicated funding. Substantial infrastructure investment and institutional commitment are essential to remedy the current deficiencies. Keywords: Guidelines, Equity, Late-effects References: 1. Best practice pathway for pelvic radiotherapy disease. https://www.prda.org.uk2. Clinical Oncology Gynaecological cancer: RCR consensus statements, April 2024. https://www.rcr.ac.uk/our-services/all-our- publications/clinical-oncology- publications/gynaecological-cancer-rcr-consensus- statements/ Lean Six Sigma and Automatic Couch Correction to Improve Daily Patient Repositioning in Vertebral Metastases Leonardo Nicotera 1,2 , Andrea Bresolin 2 , Carmela Galdieri 1,2 , Aurora Zucca 2 , Simone Antonetti 2 , Ciro Franzese 1,2 , Marta Scorsetti 1,2 , Pietro Mancosu 1,2 1 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy. 2 Radiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy Digital Poster 4444
Made with FlippingBook - Share PDF online